Transcriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genes.
Transcriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genes.
复制标题
DOI:
10.1016/j.celrep.2013.04.035
复制
发表时间:
2013-06-27
期刊:
影响因子:
8.8
通讯作者:
Goldman SA
中科院分区:
文献类型:
--
作者:
Auvergne RM;Sim FJ;Wang S;Chandler-Militello D;Burch J;Al Fanek Y;Davis D;Benraiss A;Walter K;Achanta P;Johnson M;Quinones-Hinojosa A;Natesan S;Ford HL;Goldman SA
Glial progenitor cells (GPCs) are a potential source of malignant gliomas. We used A2B5-based sorting to extract tumorigenic GPCs from human gliomas spanning WHO grades II-IV. mRNA profiling identified a cohort of genes that distinguished tumor-initiating progenitor cells (TPCs) from A2B5+ GPCs isolated from normal white matter. A core set of genes and pathways was substantially dysregulated in A2B5+ TPCs, that included the transcription factor SIX1, and its principal co-factors, EYA1 and DACH2. shRNAi silencing of SIX1 inhibited the expansion of glioma TPCs in vitro and in vivo, suggesting a critical and unrecognized role of the SIX1-EYA1-DACH2 system in glioma genesis or progression. By comparing the expression patterns of glioma TPCs to normal GPCs, we have identified a discrete set of pathways by which glial tumorigenesis may be better understood, and more specifically targeted.